Physician profile
Krisi A Causa
NPI 1376773317
$8,419.31
in general payments reported to CMS, 2019-2025
17 companies · $451 in 2025
The $451 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2021: $526 · 2022: $1,116 · 2023: $1,797 · 2024: $4,375 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $2,078 · Food and Beverage: $2,046.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $2,077.86 |
| Food and Beverage | $2,046.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,999.76 | 2023-2024 | Da Vinci Surgical System |
| Smith+Nephew, INC. | $1,191.41 | 2019-2025 | Collagenase Santyl |
| Depuy Synthes Sales INC. | $872.25 | 2021-2025 | Matrixrib |
| Polynovo North America LLC | $457.24 | 2021-2025 | Novosorb Btm |
| Avita Medical Americas, LLC | $250.95 | 2021-2024 | |
| Acera Surgical, INC. | $145.35 | 2022 | |
| Vericel Corporation | $122.71 | 2022-2025 | Nexobrid, Epicel (Cultured Epidermal Autografts) |
| Coloplast Corp | $100.99 | 2019 | |
| Davol INC. | $71.66 | 2024 | |
| Solventum Corporation | $37.34 | 2025 | V.A.C. Veraflo Cleanse Choice |
| Teleflex LLC | $31.08 | 2023 | Quikclot |
| Molnlycke Health Care US, LLC | $27.70 | 2022 | |
| Kerecis Limited | $23.86 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Biotissue Holdings INC. | $23.52 | 2024 | |
| Access Pro Medical, LLC | $23.47 | 2025 | Matriderm |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $23.09 | 2022 | |
| Mimedx Group, INC. | $16.93 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krisi Causa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.